KORA lung- healthy control subjects | SHIP lung-healthy control subjects | Pooled control group | COPD grade 1 | COPD grade 2 | COPD grade 3 | COPD grade 4 | Total COPD cohort | p-value (total cohort vs. pooled control subjects) | |
---|---|---|---|---|---|---|---|---|---|
n | 1,506 | 2,999 | 4,505 | 204 | 954 | 869 | 248 | 2,275 | |
age (years) | 63.4 (11.8) | 58.1 (10.8) | 59.9 (11.4) | 66.1 (8.7) | 65.7 (8.5) | 65.0 (8.2) | 62.1 (8.0) | 65.1 (8.4) | <0.0001 a |
% age < 55 years | 28.0 (421) | 39.7 (1,190) | 35.8 (1,611) | 9.8 (20) | 10.2 (97) | 11.1 (96) | 18.2 (45) | 11.3 (258) | <0.0001 b |
% age 55-64 years | 28.0 (421) | 28.8 (863) | 28.5 (1,284) | 27.5 (56) | 31.9 (304) | 34.4 (299) | 43.2 (107) | 33.7 (766) | |
% age 65-74 years | 21.4 (322) | 24.5 (734) | 23.4 (1,056) | 48.0 (98) | 44.6 (425) | 44.0 (382) | 31.9 (79) | 43.3 (984) | |
% age > 74 years | 22.7 (342) | 7.1 (212) | 12.3 (554) | 14.7 (30) | 13.4 (128) | 10.6 (92) | 6.9 (17) | 11.7 (267) | |
% males | 48.1 (724) | 49.9 (1,496) | 49.3 | 60.3 (123) | 60.6 (578) | 61.1 (531) | 64.1 (159) | 61.1 | <0.0001 b |
FEV1 (liter) | 3.06 (0.9) | 3.16 (0.8) | 3.13 (0.8) | 2.62 (0.6) | 1.85 (0.5) | 1.20 (0.3) | 0.75 (0.2) | 1.55 (0.6) | <0.0001 a |
FVC (liter) | 3.92 (1.1) | 3.96 (1.0) | 3.95 (1.1) | 4.11 (0.9) | 3.31 (0.9) | 2.67 (0.8) | 2.05 (0.6) | 3.00 (1.0) | <0.0001 a |
% basic education (≤9 school years) | 56.2 (847) | 21.8 (854) | 33.3 (1,501) | 48.0 (98) | 52.1 (497) | 60.0 (521) | 57.7 (143) | 55.3 (1,259) | <0.0001 b |
% secondary education (10–11 school years) | 22.7 (342) | 52.8 (1,584) | 42.8 (1,926) | 25.5 (52) | 28.6 (273) | 25.2 (219) | 29.4 (73) | 27.1 (617) | |
% higher education (>11 school years) | 21.1 (317) | 25.4 (761) | 23.9 (1,078) | 26.5 (54) | 19.3 (184) | 14.8 (129) | 12.9 (32) | 17.5 (399) | |
% smoker | 11.3 (170) | 16.1 (484) | 14.5 (654) | 29.9 (61) | 28.9 (276) | 21.8 (189) | 14.5 (36) | 24.7 (562) | <0.0001 b |
% former smoker | 39.2 (590) | 44.4 (1,332) | 42.7 (1,922) | 62.8 (128) | 63.7 (608) | 72.6 (631) | 80.2 (199) | 68.8 (1,566) | |
% never smoker | 49.5 (746) | 39.5 (1,183) | 42.8 (1,929) | 7.4 (15) | 7.3 (70) | 5.6 (49) | 5.2 (13) | 6.5 (147) | |
BMI (kg/m2) | 28.2 (4.7) | 28.6 (4.7) | 28.4 (4.7) | 26.6 (4.7) | 27.5 (5.1) | 26.4 (5.4) | 24.4 (5.0) | 26.7 (5.2) | <0.0001 a |
% normal weight (18.5 ≤ BMI < 25) | 24.4 (368) | 22.7 (681) | 23.3 (1,049) | 36.8 (75) | 32.5 (310) | 38.4 (334) | 50.0 (124) | 37.1 (843) | <0.0001 b |
% overweight (25 ≤ BMI < 30) | 45.8 (690) | 43.8 (1,313) | 44.5 (2,003) | 41.7 (85) | 39.0 (372) | 36.1 (314) | 28.6 (71) | 37.0 (842) | |
% obese (BMI ≥ 30) | 29.6 (445) | 33.4 (1,003) | 32.1 (1,448) | 20.1 (41) | 27.0 (258) | 20.9 (182) | 11.7 (29) | 22.4 (510) | |
% underweight (BMI < 18.5) | 0.2 (3) | 0.1 (2) | 0.1 (5) | 1.5 (3) | 1.5 (14) | 4.5 (39) | 9.7 (24) | 3.5 (80) | |
% diabetes | 10.4 (156) | 13.3 (399) | 12.3 (555) | 10.3 (21) | 13.3 (127) | 12.8 (111) | 11.3 (28) | 12.6 (287) | 0.73 b |
% stroke | 4.1 (61) | 2.5 (75) | 3.0 (136) | 3.9 (8) | 4.3 (41) | 4.8 (42) | 2.4 (6) | 4.3 (97) | 0.008 b |
% myocardial infarction | 5.1 (76) | 3.5 (106) | 4.0 (182) | 6.4 (13) | 8.8 (84) | 9.6 (83) | 5.2 (13) | 8.5 (193) | <0.0001 b |
% cancer | 9.5 (143) | 8.1 (242) | 8.6 (385) | 11.8 (24) | 12.2 (116) | 10.1 (88) | 7.3 (18) | 10.8 (246) | 0.002 b |
% arthritis | 12.4 (186) | 5.6 (168) | 7.9 (354) | 10.3 (21) | 8.1 (77) | 8.6 (75) | 4.8 (12) | 8.1 (185) | 0.69 b |
EQ-5D utility score | 0.90 (0.14) | 0.90 (0.14) | 0.90 (0.14) | 0.85 (0.18) | 0.84 (0.19) | 0.81 (0.21) | 0.74 (0.24) | 0.82 (0.21) | <0.0001 a |
EQ-5D valuation score | 0.76 (0.14) | 0.77 (0.13) | 0.77 (0.13) | 0.71 (0.14) | 0.68 (0.16) | 0.64 (0.17) | 0.58 (0.17) | 0.66 (0.17) | <0.0001 a |